Muhammad Adnan Shereen

5.8k total citations · 1 hit paper
38 papers, 3.8k citations indexed

About

Muhammad Adnan Shereen is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Muhammad Adnan Shereen has authored 38 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Muhammad Adnan Shereen's work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Viral Infections and Vectors (5 papers). Muhammad Adnan Shereen is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Viral Infections and Vectors (5 papers). Muhammad Adnan Shereen collaborates with scholars based in China, Pakistan and Saudi Arabia. Muhammad Adnan Shereen's co-authors include Suliman Khan, Nadia Bashir, Rabeea Siddique, Abeer Kazmi, Ashaq Ali, Jianguo Wu, Wenbiao Wang, Kailang Wu, Mengzhou Xue and Qian Bai and has published in prestigious journals such as The FASEB Journal, FEBS Letters and Journal of Clinical Microbiology.

In The Last Decade

Muhammad Adnan Shereen

36 papers receiving 3.7k citations

Hit Papers

COVID-19 infection: Emergence, transmission, and characte... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k

Peers

Muhammad Adnan Shereen
Muhammad Adnan Shereen
Citations per year, relative to Muhammad Adnan Shereen Muhammad Adnan Shereen (= 1×) peers Khan Sharun

Countries citing papers authored by Muhammad Adnan Shereen

Since Specialization
Citations

This map shows the geographic impact of Muhammad Adnan Shereen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Adnan Shereen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Adnan Shereen more than expected).

Fields of papers citing papers by Muhammad Adnan Shereen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Adnan Shereen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Adnan Shereen. The network helps show where Muhammad Adnan Shereen may publish in the future.

Co-authorship network of co-authors of Muhammad Adnan Shereen

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Adnan Shereen. A scholar is included among the top collaborators of Muhammad Adnan Shereen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Adnan Shereen. Muhammad Adnan Shereen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shereen, Muhammad Adnan, Sadia Mehmood Satti, Asim Abbasi, et al.. (2025). Investigating the Polystyrene (PS) Biodegradation Potential of Phanerochaete chrysosporium Strain NA3: A Newly Isolated Soil Fungus. Life. 15(6). 869–869.
2.
Shereen, Muhammad Adnan, Aftab Ahmad, Sadia Mehmood Satti, et al.. (2024). Plant extract preparation and green synthesis of silver nanoparticles using Swertia chirata: Characterization and antimicrobial activity against selected human pathogens. Heliyon. 10(6). e28038–e28038. 15 indexed citations
3.
Shafiq, Muhammad, et al.. (2023). Second‐Line Antiretroviral Treatment Outcome in HIV‐Infected Patients Coinfected with Tuberculosis in Pakistan. BioMed Research International. 2023(1). 4187488–4187488. 2 indexed citations
4.
Luo, Zhen, Mingfu Tian, Rui Su, et al.. (2023). Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication. Journal of Medical Virology. 95(2). e28527–e28527. 7 indexed citations
5.
Tian, Mingfu, Weiyong Liu, Xiang Li, et al.. (2021). HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduction and Targeted Therapy. 6(1). 308–308. 154 indexed citations
6.
Pan, Pan, Geng Li, Miaomiao Shen, et al.. (2021). DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction. PLoS Pathogens. 17(7). e1008603–e1008603. 48 indexed citations
7.
Huang, Siyu, Pin Wan, Shanyu Huang, et al.. (2021). The APC10 subunit of the anaphase‐promoting complex/cyclosome orchestrates NLRP3 inflammasome activation during the cell cycle. FEBS Letters. 595(19). 2463–2478. 1 indexed citations
8.
Shereen, Muhammad Adnan, et al.. (2021). In vitro efficacy of polymer coated miltefosine drug against leishmania tropica. Journal of Parasitic Diseases. 46(2). 366–376. 8 indexed citations
9.
Luo, Zhen, Chengliang Zhu, Muhammad Adnan Shereen, et al.. (2021). Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage. Frontiers in Medicine. 8. 690523–690523. 3 indexed citations
10.
Shereen, Muhammad Adnan, Nadia Bashir, Rui Su, et al.. (2021). Zika virus dysregulates the expression of astrocytic genes involved in neurodevelopment. PLoS neglected tropical diseases. 15(4). e0009362–e0009362. 17 indexed citations
11.
Sajid, Muhammad, Hafiz Ullah, Kun Yan, et al.. (2021). The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression. Frontiers in Immunology. 12. 634937–634937. 39 indexed citations
12.
Bashir, Nadia, Muhammad Adnan Shereen, Abeer Kazmi, Muhammad Sajid, & Hafiz Ullah. (2020). A retrospective analysis of pyogenic liver abscess and antibiotic resistivity of common pathogens in Peshawar. Biomedical Research and Therapy. 7(12). 4190–4196. 1 indexed citations
13.
Khan, Suliman, Ghulam Nabi, Guang Han, et al.. (2020). Novel coronavirus: how things are in Wuhan. Clinical Microbiology and Infection. 26(4). 399–400. 49 indexed citations
14.
Tian, Mingfu, Weiyong Liu, Qi Zhang, et al.. (2020). MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway. Cell Reports. 33(3). 108297–108297. 59 indexed citations
15.
Wang, Wenbiao, Dingwen Hu, Caifeng Wu, et al.. (2020). STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathogens. 16(3). e1008335–e1008335. 172 indexed citations
16.
Liu, Rui, Xinghui Liu, Yuan Li, et al.. (2020). Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis. International Immunopharmacology. 86. 106746–106746. 33 indexed citations
17.
Khan, Suliman, Rabeea Siddique, Ashaq Ali, et al.. (2020). The spread of novel coronavirus has created an alarming situation worldwide. Journal of Infection and Public Health. 13(4). 469–471. 36 indexed citations
18.
Qi, Zhang, Weiyong Liu, Wenbiao Wang, et al.. (2019). Dengue Virus Infection Activates Interleukin-1β to Induce Tissue Injury and Vascular Leakage. Frontiers in Microbiology. 10. 2637–2637. 36 indexed citations
19.
Luo, Zhen, Rui Su, Wenbiao Wang, et al.. (2019). EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PLoS Pathogens. 15(11). e1008142–e1008142. 78 indexed citations
20.
Hussein, Ahmed A., et al.. (2009). Protective immunity induced by co-injection of mixture of Mannan and B-glucan immunostimulant substances with the inactivated bivalent AI-ND vaccine in broiler chickens.. 57(4). 649–667. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026